{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:19:43Z","timestamp":1785154783374,"version":"3.55.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s11064-022-03746-2","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T14:02:46Z","timestamp":1663336966000},"page":"39-53","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Stem Cells and Natural Agents in the Management of Neurodegenerative Diseases: A New Approach"],"prefix":"10.1007","volume":"48","author":[{"given":"Aranka","family":"Brockmueller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Kian","family":"Movaeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lena","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdol-Mohammad","family":"Kajbafzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Shakibaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh Majidi","family":"Zolbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"3746_CR1","doi-asserted-by":"crossref","first-page":"6565396","DOI":"10.1155\/2020\/6565396","volume":"2020","author":"NS Mohd Sairazi","year":"2020","unstructured":"Mohd Sairazi NS, Sirajudeen KNS (2020) Natural products and their bioactive compounds: neuroprotective potentials against neurodegenerative diseases. Evid Complement Altern Med 2020:6565396","journal-title":"Evid Complement Altern Med"},{"key":"3746_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/NDT.S78226","volume":"11","author":"A Yildiz-Unal","year":"2015","unstructured":"Yildiz-Unal A, Korulu S, Karabay A (2015) Neuroprotective strategies against calpain-mediated neurodegeneration. Neuropsychiatr Dis Treat 11:297\u2013310","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3746_CR3","doi-asserted-by":"crossref","unstructured":"Singh A, Kukreti R, Saso L, Kukreti S (2019) Oxidative stress: a key modulator in neurodegenerative diseases. Molecules (Basel, Switzerland) 24(8).","DOI":"10.3390\/molecules24081583"},{"key":"3746_CR4","doi-asserted-by":"publisher","first-page":"2105607","DOI":"10.1155\/2019\/2105607","volume":"2019","author":"G Cenini","year":"2019","unstructured":"Cenini G, Lloret A, Cascella R (2019) Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view. Oxid Med Cell Longev 2019:2105607","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"3746_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","volume":"29","author":"HM Gao","year":"2008","unstructured":"Gao HM, Hong JS (2008) Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol 29(8):357\u2013365","journal-title":"Trends Immunol"},{"key":"3746_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-3-7091-0643-3_7","volume":"65","author":"KA Jellinger","year":"2003","unstructured":"Jellinger KA (2003) General aspects of neurodegeneration. J Neural Transm Suppl 65:101\u2013144","journal-title":"J Neural Transm Suppl"},{"issue":"3","key":"3746_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/0963689717723636","volume":"27","author":"YH Chang","year":"2018","unstructured":"Chang YH, Wu KC, Harn HJ, Lin SZ, Ding DC (2018) Exosomes and stem cells in degenerative disease diagnosis and therapy. Cell Transplant 27(3):349\u2013363","journal-title":"Cell Transplant"},{"key":"3746_CR8","unstructured":"Fachbeitrag Gesundheitsindustrie BW PDKB (2022) Neurodegenerative Krankheiten: Gesundheitsindustrie BW. https:\/\/www.gesundheitsindustrie-bw.de\/fachbeitrag\/dossier\/neurodegenerative-krankheiten. Accessed 23 Aug 2022"},{"issue":"3","key":"3746_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000509268","volume":"83","author":"P Yao","year":"2020","unstructured":"Yao P, Zhou L, Zhu L, Zhou B, Yu Q (2020) Mesenchymal stem cells: a potential therapeutic strategy for neurodegenerative diseases. Eur Neurol 83(3):235\u2013241","journal-title":"Eur Neurol"},{"issue":"2","key":"3746_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/azo.12397","volume":"103","author":"A Alesci","year":"2022","unstructured":"Alesci A, Pergolizzi S, Lo Cascio P, Fumia A, Lauriano ER (2022) Neuronal regeneration: vertebrates comparative overview and new perspectives for neurodegenerative diseases. Acta Zoologica 103(2):129\u2013140","journal-title":"Acta Zoologica"},{"issue":"1","key":"3746_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00441-017-2738-1","volume":"371","author":"X Zhao","year":"2018","unstructured":"Zhao X, Moore DL (2018) Neural stem cells: developmental mechanisms and disease modeling. Cell Tissue Res 371(1):1\u20136","journal-title":"Cell Tissue Res"},{"key":"3746_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopha.2017.09.114","volume":"96","author":"W Huang","year":"2017","unstructured":"Huang W, Cheng P, Yu K, Han Y, Song M, Li Y (2017) Hyperforin attenuates aluminum-induced A\u03b2 production and Tau phosphorylation via regulating Akt\/GSK-3\u03b2 signaling pathway in PC12 cells. Biomed Pharmacother 96:1\u20136","journal-title":"Biomed Pharmacother"},{"key":"3746_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fnmol.2017.00050","volume":"10","author":"H Bahmad","year":"2017","unstructured":"Bahmad H, Hadadeh O, Chamaa F, Cheaito K, Darwish B, Makkawi AK et al (2017) Modeling human neurological and neurodegenerative diseases: from induced pluripotent stem cells to neuronal differentiation and its applications in neurotrauma. Front Mol Neurosci 10:50","journal-title":"Front Mol Neurosci"},{"key":"3746_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.mam.2015.06.007","volume":"43\u201344","author":"AA Sproul","year":"2015","unstructured":"Sproul AA (2015) Being human: the role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer\u2019s disease models. Mol Aspects Med 43\u201344:54\u201365","journal-title":"Mol Aspects Med"},{"issue":"5","key":"3746_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/neup.12020","volume":"33","author":"SU Kim","year":"2013","unstructured":"Kim SU, Lee HJ, Kim YB (2013) Neural stem cell-based treatment for neurodegenerative diseases. Neuropathology 33(5):491\u2013504","journal-title":"Neuropathology"},{"issue":"2","key":"3746_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2174\/1574888X16666210810103838","volume":"17","author":"N Puranik","year":"2022","unstructured":"Puranik N, Arukha AP, Yadav SK, Yadav D, Jin JO (2022) Exploring the role of stem cell therapy in treating neurodegenerative diseases: challenges and current perspectives. Curr Stem Cell Res Ther 17(2):113\u2013125","journal-title":"Curr Stem Cell Res Ther"},{"key":"3746_CR17","doi-asserted-by":"crossref","unstructured":"Sairazi NSM, Sirajudeen KNS (2020) Natural products and their bioactive compounds: neuroprotective potentials against neurodegenerative diseases. Evid Based Complement Alternat Med 2020:6565396","DOI":"10.1155\/2020\/6565396"},{"key":"3746_CR18","doi-asserted-by":"crossref","unstructured":"Brockmueller A, Shayan P, Shakibaei M (2022) Evidence that \u03b21-integrin is required for the anti-viability and anti-proliferative effect of resveratrol in CRC cells. Int J Mol Sci 23(9).","DOI":"10.3390\/ijms23094714"},{"key":"3746_CR19","doi-asserted-by":"crossref","unstructured":"Buhrmann C, Brockmueller A, Mueller AL, Shayan P, Shakibaei M (2021) Curcumin attenuates environment-derived osteoarthritis by Sox9\/NF-kB signaling axis. Int J Mol Sci 22(14).","DOI":"10.3390\/ijms22147645"},{"key":"3746_CR20","doi-asserted-by":"crossref","unstructured":"Mueller AL, Brockmueller A, Kunnumakkara AB, Shakibaei M. Calebin A (2022) A compound of turmeric, down-regulates inflammation in tenocytes by NF-\u03baB\/scleraxis signaling. Int J Mol Sci 23(3).","DOI":"10.3390\/ijms23031695"},{"issue":"1","key":"3746_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12640-016-9600-1","volume":"30","author":"SL Costa","year":"2016","unstructured":"Costa SL, Silva VD, Dos Santos SC, Santos CC, Paris I, Mu\u00f1oz P et al (2016) Impact of plant-derived flavonoids on neurodegenerative diseases. Neurotox Res 30(1):41\u201352","journal-title":"Neurotox Res"},{"issue":"3","key":"3746_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2174\/1570159X16666180911124605","volume":"17","author":"MU Rehman","year":"2019","unstructured":"Rehman MU, Wali AF, Ahmad A, Shakeel S, Rasool S, Ali R et al (2019) Neuroprotective strategies for neurological disorders by natural products: an update. Curr Neuropharmacol 17(3):247\u2013267","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"3746_CR23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s12031-021-01922-7","volume":"72","author":"A Bandiwadekar","year":"2022","unstructured":"Bandiwadekar A, Jose J, Khayatkashani M, Habtemariam S, Khayat Kashani HR, Nabavi SM (2022) Emerging novel approaches for the enhanced delivery of natural products for the management of neurodegenerative diseases. J Mol Neurosci 72(3):653\u2013676","journal-title":"J Mol Neurosci"},{"key":"3746_CR24","doi-asserted-by":"crossref","unstructured":"Novak V, Rogelj B, \u017dupunski V (2021) Therapeutic potential of polyphenols in amyotrophic lateral sclerosis and frontotemporal dementia. Antioxidants (Basel, Switzerland) 10(8).","DOI":"10.3390\/antiox10081328"},{"issue":"35","key":"3746_CR25","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.2174\/1381612826666200621171302","volume":"26","author":"JH Miller","year":"2020","unstructured":"Miller JH, Das V (2020) Potential for treatment of neurodegenerative diseases with natural products or synthetic compounds that stabilize microtubules. Curr Pharm Des 26(35):4362\u20134372","journal-title":"Curr Pharm Des"},{"issue":"1","key":"3746_CR26","doi-asserted-by":"publisher","first-page":"13545","DOI":"10.1038\/s41598-018-31787-7","volume":"8","author":"A Sarkar","year":"2018","unstructured":"Sarkar A, Gogia N, Glenn N, Singh A, Jones G, Powers N et al (2018) A soy protein Lunasin can ameliorate amyloid-beta 42 mediated neurodegeneration in Drosophila eye. Sci Rep 8(1):13545","journal-title":"Sci Rep"},{"issue":"1","key":"3746_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00441-020-03188-8","volume":"381","author":"B Constanze","year":"2020","unstructured":"Constanze B, Popper B, Aggarwal BB, Shakibaei M (2020) Evidence that TNF-\u03b2 suppresses osteoblast differentiation of mesenchymal stem cells and resveratrol reverses it through modulation of NF-\u03baB, Sirt1 and Runx2. Cell Tissue Res 381(1):83\u201398","journal-title":"Cell Tissue Res"},{"issue":"4","key":"3746_CR28","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1186\/ar3065","volume":"12","author":"C Buhrmann","year":"2010","unstructured":"Buhrmann C, Mobasheri A, Matis U, Shakibaei M (2010) Curcumin mediated suppression of nuclear factor-\u03baB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment. Arthritis Res Ther 12(4):R127","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3746_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","volume":"9","author":"PS Aisen","year":"2017","unstructured":"Aisen PS, Cummings J, Jack CR Jr, Morris JC, Sperling R, Fr\u00f6lich L et al (2017) On the path to 2025: understanding the Alzheimer\u2019s disease continuum. Alzheimer\u2019s research & therapy 9(1):60","journal-title":"Alzheimer's research & therapy"},{"issue":"3","key":"3746_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","volume":"15","author":"A As","year":"2019","unstructured":"As A (2019) 2019 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 15(3):321\u2013387","journal-title":"Alzheimers Dement"},{"issue":"1","key":"3746_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JAD-2001-3111","volume":"3","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer\u2019s disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimer\u2019s Dis 3(1):75\u201380","journal-title":"J Alzheimer's Dis"},{"key":"3746_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114398","volume":"188","author":"L van Olst","year":"2022","unstructured":"van Olst L, Coenen L, Nieuwland JM, Rodriguez-Mogeda C, de Wit NM, Kamermans A et al (2022) Crossing borders in Alzheimer\u2019s disease: a T cell\u2019s perspective. Adv Drug Deliv Rev 188:114398","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"3746_CR33","first-page":"331","volume":"3","author":"MA Markus","year":"2008","unstructured":"Markus MA, Morris BJ (2008) Resveratrol in prevention and treatment of common clinical conditions of aging. Clin Interv Aging 3(2):331\u2013339","journal-title":"Clin Interv Aging"},{"key":"3746_CR34","doi-asserted-by":"crossref","unstructured":"Gomes RC, Sakata RP, Almeida WP, Coelho F (2019) Spirocyclohexadienones as an uncommon scaffold for acetylcholinesterase inhibitory activity. Med Chem (Shariqah (United Arab Emirates)) 15(4):373\u201382.","DOI":"10.2174\/1573406414666181109114214"},{"issue":"1","key":"3746_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/molecules23010117","volume":"23","author":"S Habtemariam","year":"2018","unstructured":"Habtemariam S (2018) Iridoids and other monoterpenes in the Alzheimer\u2019s brain: recent development and future prospects. Molecules (Basel, Switzerland) 23(1):117","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"4","key":"3746_CR36","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006171","volume":"2","author":"S Weintraub","year":"2012","unstructured":"Weintraub S, Wicklund AH, Salmon DP (2012) The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med 2(4):a006171","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"3746_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/1533317508327587","volume":"24","author":"F Zhongling","year":"2009","unstructured":"Zhongling F, Gang Z, Lei Y (2009) Neural stem cells and Alzheimer\u2019s disease: challenges and hope. Am J Alzheimers Dis Other Demen 24(1):52\u201357","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"1","key":"3746_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41380-019-0468-3","volume":"25","author":"J Penney","year":"2020","unstructured":"Penney J, Ralvenius WT, Tsai L-H (2020) Modeling Alzheimer\u2019s disease with iPSC-derived brain cells. Mol Psychiatry 25(1):148\u2013167","journal-title":"Mol Psychiatry"},{"issue":"4","key":"3746_CR39","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.neuroscience.2006.09.017","volume":"145","author":"X Zeng","year":"2007","unstructured":"Zeng X, Rao MS (2007) Human embryonic stem cells: long term stability, absence of senescence and a potential cell source for neural replacement. Neuroscience 145(4):1348\u20131358","journal-title":"Neuroscience"},{"issue":"1","key":"3746_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000094383","volume":"15","author":"K Heese","year":"2006","unstructured":"Heese K, Low JW, Inoue N (2006) Nerve growth factor, neural stem cells and Alzheimer\u2019s disease. Neurosignals 15(1):1\u201312","journal-title":"Neurosignals"},{"issue":"1","key":"3746_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1073\/pnas.2634794100","volume":"101","author":"K Jin","year":"2004","unstructured":"Jin K, Peel AL, Mao XO, Xie L, Cottrell BA, Henshall DC et al (2004) Increased hippocampal neurogenesis in Alzheimer\u2019s disease. Proc Natl Acad Sci USA 101(1):343\u2013347","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"3746_CR42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1124\/jpet.120.000324","volume":"377","author":"Z Si","year":"2021","unstructured":"Si Z, Wang X (2021) Stem cell therapies in Alzheimer\u2019s disease: applications for disease modeling. J Pharmacol Exp Ther 377(2):207\u2013217","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"3746_CR43","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3892\/ol.2016.4857","volume":"12","author":"H Jiao","year":"2016","unstructured":"Jiao H, Shi K, Zhang W, Yang L, Yang L, Guan F et al (2016) Therapeutic potential of human amniotic membrane-derived mesenchymal stem cells in APP transgenic mice. Oncol Lett 12(3):1877\u20131883","journal-title":"Oncol Lett"},{"issue":"20","key":"3746_CR44","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1111\/j.1742-4658.2011.08228.x","volume":"278","author":"TL Williams","year":"2011","unstructured":"Williams TL, Serpell LC (2011) Membrane and surface interactions of Alzheimer\u2019s A\u03b2 peptide\u2013insights into the mechanism of cytotoxicity. FEBS J 278(20):3905\u20133917","journal-title":"FEBS J"},{"issue":"8","key":"3746_CR45","first-page":"1089","volume":"6","author":"S Habtemariam","year":"2011","unstructured":"Habtemariam S (2011) The therapeutic potential of Berberis darwinii stem-bark: quantification of berberine and in vitro evidence for Alzheimer\u2019s disease therapy. Nat Prod Commun 6(8):1089\u20131090","journal-title":"Nat Prod Commun"},{"key":"3746_CR46","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.phytol.2016.10.005","volume":"18","author":"M Roselli","year":"2016","unstructured":"Roselli M, Cavalluzzi MM, Bruno C, Lovece A, Carocci A, Franchini C et al (2016) Synthesis and evaluation of berberine derivatives and analogs as potential antiacetylcholinesterase and antioxidant agents. Phytochem Lett 18:150\u2013156","journal-title":"Phytochem Lett"},{"key":"3746_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biopha.2018.11.043","volume":"110","author":"SO Rahman","year":"2019","unstructured":"Rahman SO, Panda BP, Parvez S, Kaundal M, Hussain S, Akhtar M et al (2019) Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by A\u03b2 peptides in animal model of Alzheimer\u2019s disease. Biomed Pharmacother 110:47\u201358","journal-title":"Biomed Pharmacother"},{"key":"3746_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/172801","volume":"2015","author":"J Thomas","year":"2015","unstructured":"Thomas J, Thomas CJ, Radcliffe J, Itsiopoulos C (2015) Omega-3 fatty acids in early prevention of inflammatory neurodegenerative disease: a focus on Alzheimer\u2019s disease. Biomed Res Int 2015:172801","journal-title":"Biomed Res Int"},{"issue":"4","key":"3746_CR49","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2174\/1574884713666180807145648","volume":"13","author":"TA Ajith","year":"2018","unstructured":"Ajith TA (2018) A recent update on the effects of omega-3 fatty acids in Alzheimer\u2019s disease. Curr Clin Pharmacol 13(4):252\u2013260","journal-title":"Curr Clin Pharmacol"},{"key":"3746_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153676","volume":"91","author":"J Manochkumar","year":"2021","unstructured":"Manochkumar J, Doss CGP, El-Seedi HR, Efferth T, Ramamoorthy S (2021) The neuroprotective potential of carotenoids in vitro and in vivo. Phytomedicine 91:153676","journal-title":"Phytomedicine"},{"issue":"8","key":"3746_CR51","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3390\/molecules24081519","volume":"24","author":"S Habtemariam","year":"2019","unstructured":"Habtemariam S (2019) Natural products in Alzheimer\u2019s disease therapy: would old therapeutic approaches fix the broken promise of modern medicines? Molecules (Basel, Switzerland) 24(8):1519","journal-title":"Molecules (Basel, Switzerland)"},{"key":"3746_CR52","doi-asserted-by":"crossref","unstructured":"Servello A, Leccese V, Ettorre E (2020) Natural products for neurocognitive disorders. Exon Publ 205\u2013220.","DOI":"10.36255\/exonpublications.alzheimersdisease.2020.ch12"},{"issue":"23","key":"3746_CR53","first-page":"4012","volume":"28","author":"F Elifani","year":"2019","unstructured":"Elifani F, Amico E, Pepe G, Capocci L, Castaldo S, Rosa P et al (2019) Curcumin dietary supplementation ameliorates disease phenotype in an animal model of Huntington\u2019s disease. Hum Mol Genet 28(23):4012\u20134021","journal-title":"Hum Mol Genet"},{"key":"3746_CR54","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.nbd.2019.02.015","volume":"127","author":"B Teter","year":"2019","unstructured":"Teter B, Morihara T, Lim G, Chu T, Jones M, Zuo X et al (2019) Curcumin restores innate immune Alzheimer\u2019s disease risk gene expression to ameliorate Alzheimer pathogenesis. Neurobiol Dis 127:432\u2013448","journal-title":"Neurobiol Dis"},{"issue":"6","key":"3746_CR55","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.3390\/ijms21062084","volume":"21","author":"A Shaito","year":"2020","unstructured":"Shaito A, Posadino AM, Younes N, Hasan H, Halabi S, Alhababi D et al (2020) Potential adverse effects of resveratrol: a literature review. Int J Mol Sci 21(6):2084","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3746_CR56","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1080\/07391102.2018.1511475","volume":"37","author":"RK Saini","year":"2019","unstructured":"Saini RK, Shuaib S, Goyal D, Goyal B (2019) Insights into the inhibitory mechanism of a resveratrol and clioquinol hybrid against A\u03b242 aggregation and protofibril destabilization: a molecular dynamics simulation study. J Biomol Struct Dyn 37(12):3183\u20133197","journal-title":"J Biomol Struct Dyn"},{"issue":"6","key":"3746_CR57","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2174\/1871527317666180508123050","volume":"17","author":"T Beg","year":"2018","unstructured":"Beg T, Jyoti S, Naz F, Ali F, Ali SK, Reyad AM et al (2018) Protective effect of kaempferol on the transgenic Drosophila model of Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 17(6):421\u2013429","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"10","key":"3746_CR58","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.3390\/molecules23102485","volume":"23","author":"BK Velmurugan","year":"2018","unstructured":"Velmurugan BK, Rathinasamy B, Lohanathan BP, Thiyagarajan V, Weng C-F (2018) Neuroprotective role of phytochemicals. Molecules (Basel, Switzerland) 23(10):2485","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"9","key":"3746_CR59","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00204-019-02538-y","volume":"93","author":"M Simunkova","year":"2019","unstructured":"Simunkova M, Alwasel SH, Alhazza IM, Jomova K, Kollar V, Rusko M et al (2019) Management of oxidative stress and other pathologies in Alzheimer\u2019s disease. Arch Toxicol 93(9):2491\u20132513","journal-title":"Arch Toxicol"},{"issue":"1","key":"3746_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-019-2510-z","volume":"19","author":"N-N Yuan","year":"2019","unstructured":"Yuan N-N, Cai C-Z, Wu M-Y, Su H-X, Li M, Lu J-H (2019) Neuroprotective effects of berberine in animal models of Alzheimer\u2019s disease: a systematic review of pre-clinical studies. BMC Complement Altern Med 19(1):1\u201310","journal-title":"BMC Complement Altern Med"},{"issue":"1","key":"3746_CR61","first-page":"76","volume":"1","author":"X Chen","year":"2009","unstructured":"Chen X, Feng W, Chen Q, Yang X, Yang D, Wang D et al (2009) Effects of acetylate hyperforin on the processing of amyloid precursor protein. Int J Physiol Pathophysiol Pharmacol 1(1):76","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"issue":"20","key":"3746_CR62","doi-asserted-by":"publisher","first-page":"6156","DOI":"10.1021\/jf0490596","volume":"52","author":"CY Ang","year":"2004","unstructured":"Ang CY, Hu L, Heinze TM, Cui Y, Freeman JP, Kozak K et al (2004) Instability of St. John\u2019s wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage. J Agric Food Chem 52(20):6156\u20136164","journal-title":"J Agric Food Chem"},{"issue":"3","key":"3746_CR63","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3233\/JAD-151079","volume":"52","author":"C-H Liu","year":"2016","unstructured":"Liu C-H, Bu X-L, Wang J, Zhang T, Xiang Y, Shen L-L et al (2016) The associations between a capsaicin-rich diet and blood amyloid-\u03b2 levels and cognitive function. J Alzheimers Dis 52(3):1081\u20131088","journal-title":"J Alzheimers Dis"},{"key":"3746_CR64","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejphar.2018.10.006","volume":"842","author":"J Jin","year":"2019","unstructured":"Jin J, Wang H, Hua X, Chen D, Huang C, Chen Z (2019) An outline for the pharmacological effect of icariin in the nervous system. Eur J Pharmacol 842:20\u201332","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"3746_CR65","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1038\/s41598-022-08409-4","volume":"12","author":"TC Akinade","year":"2022","unstructured":"Akinade TC, Babatunde OO, Adedara AO, Adeyemi OE, Otenaike TA, Ashaolu OP et al (2022) Protective capacity of carotenoid trans-astaxanthin in rotenone-induced toxicity in Drosophila melanogaster. Sci Rep 12(1):4594","journal-title":"Sci Rep"},{"issue":"12","key":"3746_CR66","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1111\/jphp.12186","volume":"65","author":"J Xiao","year":"2013","unstructured":"Xiao J, Tundis R (2013) Natural products for Alzheimer\u2019s disease therapy: basic and application. J Pharm Pharmacol 65(12):1679\u20131680","journal-title":"J Pharm Pharmacol"},{"issue":"44","key":"3746_CR67","doi-asserted-by":"publisher","first-page":"9626","DOI":"10.1021\/acs.jafc.7b03252","volume":"65","author":"KA Jhang","year":"2017","unstructured":"Jhang KA, Park JS, Kim HS, Chong YH (2017) Resveratrol ameliorates tau hyperphosphorylation at Ser396 site and oxidative damage in rat hippocampal slices exposed to vanadate: implication of ERK1\/2 and GSK-3\u03b2 signaling cascades. J Agric Food Chem 65(44):9626\u20139634","journal-title":"J Agric Food Chem"},{"issue":"8","key":"3746_CR68","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1142\/S0192415X17500902","volume":"45","author":"J Sun","year":"2017","unstructured":"Sun J, Zhang X, Wang C, Teng Z, Li Y (2017) Curcumin decreases hyperphosphorylation of tau by down-regulating caveolin-1\/GSK-3\u03b2 in N2a\/APP695swe cells and APP\/PS1 double transgenic Alzheimer\u2019s disease mice. Am J Chin Med 45(8):1667\u20131682","journal-title":"Am J Chin Med"},{"issue":"1","key":"3746_CR69","first-page":"1","volume":"22","author":"E Mirzazadeh","year":"2019","unstructured":"Mirzazadeh E, Khezri S, Abtahi Froushani SM (2019) Effects of quercetin on improving the damage caused by free radicals in the rat models of multiple sclerosis. ISMJ 22(1):1\u201315","journal-title":"ISMJ"},{"key":"3746_CR70","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.lfs.2019.03.055","volume":"224","author":"E Zaplatic","year":"2019","unstructured":"Zaplatic E, Bule M, Shah SZA, Uddin MS, Niaz K (2019) Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer\u2019s disease. Life Sci 224:109\u2013119","journal-title":"Life Sci"},{"issue":"11","key":"3746_CR71","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3390\/biom9110690","volume":"9","author":"Z Nouri","year":"2019","unstructured":"Nouri Z, Fakhri S, El-Senduny FF, Sanadgol N, Abd-ElGhani GE, Farzaei MH et al (2019) On the neuroprotective effects of naringenin: pharmacological targets, signaling pathways, molecular mechanisms, and clinical perspective. Biomolecules 9(11):690","journal-title":"Biomolecules"},{"key":"3746_CR72","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2014.12.012","volume":"281","author":"C Li","year":"2015","unstructured":"Li C, Zug C, Qu H, Schluesener H, Zhang Z (2015) Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP\/PS1 mice. Behav Brain Res 281:32\u201342","journal-title":"Behav Brain Res"},{"issue":"1","key":"3746_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-6-29","volume":"6","author":"TC Theoharides","year":"2009","unstructured":"Theoharides TC (2009) Luteolin as a therapeutic option for multiple sclerosis. J Neuroinflammation 6(1):1\u20133","journal-title":"J Neuroinflammation"},{"key":"3746_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.09.002","volume":"119","author":"SF Nabavi","year":"2015","unstructured":"Nabavi SF, Braidy N, Gortzi O, Sobarzo-Sanchez E, Daglia M, Skalicka-Wo\u017aniak K et al (2015) Luteolin as an anti-inflammatory and neuroprotective agent: a brief review. Brain Res Bull 119:1\u201311","journal-title":"Brain Res Bull"},{"issue":"4","key":"3746_CR75","first-page":"1910","volume":"8","author":"Z Wei","year":"2016","unstructured":"Wei Z, Wang M, Hong M, Diao S, Liu A, Huang Y et al (2016) Icariin exerts estrogen-like activity in ameliorating EAE via mediating estrogen receptor \u03b2, modulating HPA function and glucocorticoid receptor expression. Am J Transl Res 8(4):1910","journal-title":"Am J Transl Res"},{"key":"3746_CR76","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.intimp.2018.06.022","volume":"62","author":"L Xie","year":"2018","unstructured":"Xie L, Gong W, Chen J, Xie H-W, Wang M, Yin X-P et al (2018) The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation. Int Immunopharmacol 62:227\u2013236","journal-title":"Int Immunopharmacol"},{"key":"3746_CR77","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.brainresbull.2020.08.016","volume":"164","author":"Y Li","year":"2020","unstructured":"Li Y, Song K, Zhang H, Yuan M, An N, Wei Y et al (2020) Anti-inflammatory and immunomodulatory effects of baicalin in cerebrovascular and neurological disorders. Brain Res Bull 164:314\u2013324","journal-title":"Brain Res Bull"},{"key":"3746_CR78","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1590\/S0100-879X2006005000115","volume":"40","author":"Y Zeng","year":"2007","unstructured":"Zeng Y, Song C, Ding X, Ji X, Yi L, Zhu K (2007) Baicalin reduces the severity of experimental autoimmune encephalomyelitis. Braz J Med Biol Res 40:1003\u20131010","journal-title":"Braz J Med Biol Res"},{"issue":"6","key":"3746_CR79","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.neuint.2011.07.012","volume":"59","author":"HM Mahdy","year":"2011","unstructured":"Mahdy HM, Tadros MG, Mohamed MR, Karim AM, Khalifa AE (2011) The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats. Neurochem Int 59(6):770\u2013778","journal-title":"Neurochem Int"},{"issue":"4","key":"3746_CR80","doi-asserted-by":"publisher","first-page":"342","DOI":"10.5142\/jgr.2012.36.4.342","volume":"36","author":"I-H Cho","year":"2012","unstructured":"Cho I-H (2012) Effects of Panax ginseng in neurodegenerative diseases. J Ginseng Res 36(4):342","journal-title":"J Ginseng Res"},{"issue":"6","key":"3746_CR81","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1586\/14737175.7.6.667","volume":"7","author":"J Takahashi","year":"2007","unstructured":"Takahashi J (2007) Stem cell therapy for Parkinson\u2019s disease. Expert Rev Neurother 7(6):667\u2013675","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"3746_CR82","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5483\/BMBRep.2010.43.4.233","volume":"43","author":"W-G Seol","year":"2010","unstructured":"Seol W-G (2010) Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson\u2019s disease. BMB Rep 43(4):233\u2013244","journal-title":"BMB Rep"},{"key":"3746_CR83","doi-asserted-by":"publisher","first-page":"155962","DOI":"10.1016\/j.cyto.2022.155962","volume":"157","author":"MM Rahman","year":"2022","unstructured":"Rahman MM, Mim SA, Tumpa MAA, Sarker MT, Ahmed M, Alghamdi BS et al (2022) Exploring the management approaches of cytokines including viral infection and neuroinflammation for neurological disorders. Cytokine 157:155962","journal-title":"Cytokine"},{"key":"3746_CR84","first-page":"59","volume-title":"An insight into Parkinson\u2019s disease: researches and its complexities. Smart healthcare for disease diagnosis and prevention","author":"A Saikia","year":"2020","unstructured":"Saikia A, Hussain M, Barua AR, Paul S (2020) An insight into Parkinson\u2019s disease: researches and its complexities. Smart healthcare for disease diagnosis and prevention. Elsevier, New York, pp 59\u201380"},{"issue":"7","key":"3746_CR85","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.biocel.2013.03.011","volume":"45","author":"T-W Liu","year":"2013","unstructured":"Liu T-W, Ma Z-G, Zhou Y, Xie J-X (2013) Transplantation of mouse CGR8 embryonic stem cells producing GDNF and TH protects against 6-hydroxydopamine neurotoxicity in the rat. Int J Biochem Cell Biol 45(7):1265\u20131273","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"3746_CR86","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/1673-5374.264446","volume":"15","author":"T Stoddard-Bennett","year":"2020","unstructured":"Stoddard-Bennett T, Pera RR (2020) Stem cell therapy for Parkinson\u2019s disease: safety and modeling. Neural Regen Res 15(1):36\u201340","journal-title":"Neural Regen Res"},{"issue":"7656","key":"3746_CR87","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/546015a","volume":"546","author":"D Cyranoski","year":"2017","unstructured":"Cyranoski D (2017) Trials of embryonic stem cells to launch in China. Nat News 546(7656):15","journal-title":"Nat News"},{"issue":"1","key":"3746_CR88","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/cells8010026","volume":"8","author":"T Stoddard-Bennett","year":"2019","unstructured":"Stoddard-Bennett T, Reijo PR (2019) Treatment of Parkinson\u2019s disease through personalized medicine and induced pluripotent stem cells. Cells 8(1):26","journal-title":"Cells"},{"issue":"9","key":"3746_CR89","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1007\/s11064-012-0799-9","volume":"37","author":"MM Essa","year":"2012","unstructured":"Essa MM, Vijayan RK, Castellano-Gonzalez G, Memon MA, Braidy N, Guillemin GJ (2012) Neuroprotective effect of natural products against Alzheimer\u2019s disease. Neurochem Res 37(9):1829\u20131842","journal-title":"Neurochem Res"},{"issue":"1","key":"3746_CR90","first-page":"1","volume":"3","author":"M Essa","year":"2014","unstructured":"Essa M, Braidy N, Bridge W, Subash S, Manivasagam T, Vijayan R et al (2014) Review of natural products on Parkinson\u2019s disease pathology. J Aging Res Clin Pract 3(1):1\u20138","journal-title":"J Aging Res Clin Pract"},{"issue":"1\u20132","key":"3746_CR91","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000085382","volume":"14","author":"PJ Houghton","year":"2005","unstructured":"Houghton PJ, Howes M-J (2005) Natural products and derivatives affecting neurotransmission relevant to Alzheimer\u2019s and Parkinson\u2019s disease. Neurosignals 14(1\u20132):6\u201322","journal-title":"Neurosignals"},{"issue":"4","key":"3746_CR92","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1039\/b800422f","volume":"38","author":"JP Spencer","year":"2009","unstructured":"Spencer JP (2009) The impact of flavonoids on memory: physiological and molecular considerations. Chem Soc Rev 38(4):1152\u20131161","journal-title":"Chem Soc Rev"},{"issue":"3","key":"3746_CR93","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2174\/187153007781662521","volume":"7","author":"K Vafeiadou","year":"2007","unstructured":"Vafeiadou K, Vauzour D, Spencer J (2007) Neuroinflammation and its modulation by flavonoids. Endocrine Metabolic Immune Disord Drug Targets 7(3):211\u2013224","journal-title":"Endocrine Metabolic Immune Disord Drug Targets"},{"issue":"2","key":"3746_CR94","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12640-012-9332-9","volume":"23","author":"A Anandhan","year":"2013","unstructured":"Anandhan A, Essa MM, Manivasagam T (2013) Therapeutic attenuation of neuroinflammation and apoptosis by black tea theaflavin in chronic MPTP\/probenecid model of Parkinson\u2019s disease. Neurotox Res 23(2):166\u2013173","journal-title":"Neurotox Res"},{"issue":"4","key":"3746_CR95","first-page":"334","volume":"5","author":"L-C Mishra","year":"2000","unstructured":"Mishra L-C, Singh BB, Dagenais S (2000) Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev 5(4):334\u2013346","journal-title":"Altern Med Rev"},{"issue":"5\u20136","key":"3746_CR96","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/S0891-5849(99)00107-0","volume":"27","author":"H Wang","year":"1999","unstructured":"Wang H, Joseph JA (1999) Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radical Biol Med 27(5\u20136):612\u2013616","journal-title":"Free Radical Biol Med"},{"issue":"1","key":"3746_CR97","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.expneurol.2003.08.002","volume":"184","author":"J Van Kampen","year":"2003","unstructured":"Van Kampen J, Robertson H, Hagg T, Drobitch R (2003) Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson\u2019s disease. Exp Neurol 184(1):521\u2013529","journal-title":"Exp Neurol"},{"key":"3746_CR98","doi-asserted-by":"crossref","unstructured":"Chen J-F, Xu K, Petzer JP, Staal R, Xu Y-H, Beilstein M, et al (2001) Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci 21(10):RC143-RC.","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001"},{"issue":"39","key":"3746_CR99","doi-asserted-by":"publisher","first-page":"36040","DOI":"10.1074\/jbc.M206830200","volume":"277","author":"J-F Chen","year":"2002","unstructured":"Chen J-F, Steyn S, Staal R, Petzer JP, Xu K, Van der Schyf CJ et al (2002) 8-(3-Chlorostyryl) caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism. J Biol Chem 277(39):36040\u201336044","journal-title":"J Biol Chem"},{"key":"3746_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.152954","volume":"60","author":"J Li","year":"2019","unstructured":"Li J, Long X, Hu J, Bi J, Zhou T, Guo X et al (2019) Multiple pathways for natural product treatment of Parkinson\u2019s disease: a mini review. Phytomedicine 60:152954","journal-title":"Phytomedicine"},{"issue":"2","key":"3746_CR101","first-page":"221","volume":"16","author":"J-Y Wang","year":"2005","unstructured":"Wang J-Y, Chiu J-H, Tsai T-H, Tsou A-P, Hu C-P, Chi C-W et al (2005) Gene expression profiling predicts liver responses to a herbal remedy after partial hepatectomy in mice. Int J Mol Med 16(2):221\u2013231","journal-title":"Int J Mol Med"},{"issue":"1","key":"3746_CR102","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neulet.2008.05.116","volume":"441","author":"Y Cheng","year":"2008","unstructured":"Cheng Y, He G, Mu X, Zhang T, Li X, Hu J et al (2008) Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile. Neurosci Lett 441(1):16\u201320","journal-title":"Neurosci Lett"},{"issue":"3","key":"3746_CR103","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.phymed.2004.11.006","volume":"13","author":"E Ernst","year":"2006","unstructured":"Ernst E (2006) Herbal remedies for anxiety\u2013a systematic review of controlled clinical trials. Phytomedicine 13(3):205\u2013208","journal-title":"Phytomedicine"},{"issue":"1","key":"3746_CR104","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25(1):24\u201334","journal-title":"Eur J Neurol"},{"issue":"1","key":"3746_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms3753","volume":"4","author":"J Leitman","year":"2013","unstructured":"Leitman J, Hartl FU, Lederkremer GZ (2013) Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress. Nat Commun 4(1):1\u201310","journal-title":"Nat Commun"},{"issue":"2","key":"3746_CR106","doi-asserted-by":"publisher","first-page":"102","DOI":"10.15283\/ijsc.2009.2.2.102","volume":"2","author":"W Im","year":"2009","unstructured":"Im W, Lee S-T, Chu K, Kim M, Roh J-K (2009) Stem cells transplantation and Huntington\u2019s disease. Int J Stem Cells 2(2):102","journal-title":"Int J Stem Cells"},{"issue":"1","key":"3746_CR107","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neulet.2007.05.066","volume":"423","author":"J Song","year":"2007","unstructured":"Song J, Lee S-T, Kang W, Park J-E, Chu K, Lee S-E et al (2007) Human embryonic stem cell-derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions. Neurosci Lett 423(1):58\u201361","journal-title":"Neurosci Lett"},{"issue":"2","key":"3746_CR108","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/cne.20176","volume":"475","author":"JL McBride","year":"2004","unstructured":"McBride JL, Behrstock SP, Chen EY, Jakel RJ, Siegel I, Svendsen CN et al (2004) Human neural stem cell transplants improve motor function in a rat model of Huntington\u2019s disease. J Compar Neurol 475(2):211\u2013219","journal-title":"J Compar Neurol"},{"issue":"5","key":"3746_CR109","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","volume":"134","author":"I-H Park","year":"2008","unstructured":"Park I-H, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A et al (2008) Disease-specific induced pluripotent stem cells. Cell 134(5):877\u2013886","journal-title":"Cell"},{"issue":"3","key":"3746_CR110","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1634\/stemcells.19-3-180","volume":"19","author":"P Bianco","year":"2001","unstructured":"Bianco P, Riminucci M, Gronthos S, Robey PG (2001) Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19(3):180\u2013192","journal-title":"Stem Cells"},{"issue":"2","key":"3746_CR111","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1179\/174313209X409025","volume":"32","author":"M-A Edalatmanesh","year":"2010","unstructured":"Edalatmanesh M-A, Matin MM, Neshati Z, Bahrami A-R, Kheirabadi M (2010) Systemic transplantation of mesenchymal stem cells can reduce cognitive and motor deficits in rats with unilateral lesions of the neostriatum. Neurol Res 32(2):166\u2013172","journal-title":"Neurol Res"},{"issue":"8","key":"3746_CR112","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2174\/1566524033479384","volume":"3","author":"Y Long","year":"2003","unstructured":"Long Y, Yang K (2003) Bone marrow derived cells for brain repair: recent findings and current controversies. Curr Mol Med 3(8):719\u2013725","journal-title":"Curr Mol Med"},{"issue":"2","key":"3746_CR113","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbr.2010.05.023","volume":"214","author":"ND Dey","year":"2010","unstructured":"Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J et al (2010) Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington\u2019s disease. Behav Brain Res 214(2):193\u2013200","journal-title":"Behav Brain Res"},{"issue":"9","key":"3746_CR114","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1002\/stem.1135","volume":"30","author":"I Jeon","year":"2012","unstructured":"Jeon I, Lee N, Li JY, Park IH, Park KS, Moon J et al (2012) Neuronal properties, in vivo effects, and pathology of a Huntington\u2019s disease patient-derived induced pluripotent stem cells. Stem Cells 30(9):2054\u20132062","journal-title":"Stem Cells"},{"issue":"14","key":"3746_CR115","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/0973-7847.120505","volume":"7","author":"S Choudhary","year":"2013","unstructured":"Choudhary S, Kumar P, Malik J (2013) Plants and phytochemicals for Huntington\u2019s disease. Pharmacogn Rev 7(14):81","journal-title":"Pharmacogn Rev"},{"key":"3746_CR116","first-page":"239","volume-title":"Therapeutic options for Huntington's disease: Ayurvedic medicinal plants. Food for Huntington's Disease","author":"J Nataraj","year":"2018","unstructured":"Nataraj J, Manivasagam T, Thenmozhi AJ, Babu CS, Essa MM (2018) Therapeutic options for Huntington\u2019s disease: Ayurvedic medicinal plants. Food for Huntington\u2019s Disease. Nova Science Publishers Inc, Hauppauge, pp 239\u2013249"},{"issue":"1","key":"3746_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.hermed.2015.01.002","volume":"5","author":"A Dey","year":"2015","unstructured":"Dey A, De JN (2015) Neuroprotective therapeutics from botanicals and phytochemicals against Huntington\u2019s disease and related neurodegenerative disorders. J Herbal Med 5(1):1\u201319","journal-title":"J Herbal Med"},{"key":"3746_CR118","doi-asserted-by":"crossref","unstructured":"Gohil KJ, Patel JA (2010) A review on Bacopa monniera: current research and future prospects. Int J Green Pharmacy 4(1).","DOI":"10.4103\/0973-8258.62156"},{"issue":"4","key":"3746_CR119","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.phymed.2010.08.005","volume":"18","author":"GK Shinomol","year":"2011","unstructured":"Shinomol GK (2011) Bacopa monnieri modulates endogenous cytoplasmic and mitochondrial oxidative markers in prepubertal mice brain. Phytomedicine 18(4):317\u2013326","journal-title":"Phytomedicine"},{"issue":"4","key":"3746_CR120","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s002130100815","volume":"156","author":"C Stough","year":"2001","unstructured":"Stough C, Lloyd J, Clarke J, Downey L, Hutchison C, Rodgers T et al (2001) The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology 156(4):481\u2013484","journal-title":"Psychopharmacology"},{"issue":"18","key":"3746_CR121","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4103\/0973-7847.162137","volume":"9","author":"T Isah","year":"2015","unstructured":"Isah T (2015) Rethinking Ginkgo biloba L.: medicinal uses and conservation. Pharmacogn Rev 9(18):140\u2013148","journal-title":"Pharmacogn Rev"},{"issue":"9","key":"3746_CR122","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1021\/np50123a003","volume":"58","author":"JT Baker","year":"1995","unstructured":"Baker JT, Borris RP, Cart\u00e9 B, Cordell GA, Soejarto DD, Cragg GM et al (1995) Natural product drug discovery and development: new perspectives on international collaboration. J Nat Prod 58(9):1325\u20131357","journal-title":"J Nat Prod"},{"issue":"9","key":"3746_CR123","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1745-7254.2008.00869.x","volume":"29","author":"CHOI Kt","year":"2008","unstructured":"Kt CHOI (2008) Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng CA Meyer. Acta Pharmacol Sin 29(9):1109\u20131118","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"3746_CR124","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/jphp.12398","volume":"67","author":"S Durg","year":"2015","unstructured":"Durg S, Dhadde SB, Vandal R, Shivakumar BS, Charan CS (2015) W ithania somnifera (Ashwagandha) in neurobehavioural disorders induced by brain oxidative stress in rodents: a systematic review and meta-analysis. J Pharm Pharmacol 67(7):879\u2013899","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"3746_CR125","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.pnpbp.2007.09.011","volume":"32","author":"S Kulkarni","year":"2008","unstructured":"Kulkarni S, Dhir A (2008) Withania somnifera: an Indian ginseng. Prog Neuropsychopharmacol Biol Psychiatry 32(5):1093\u20131105","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3746_CR126","doi-asserted-by":"crossref","unstructured":"Joshi T, Kumar V, Kaznacheyeva EV, Jana NR (2021) Withaferin a induces heat shock response and ameliorates disease progression in a mouse model of Huntington\u2019s disease. Mol Neurobiol 1\u201315.","DOI":"10.21203\/rs.3.rs-255652\/v1"},{"issue":"14","key":"3746_CR127","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA et al (2020) Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS. Mult Scler J 26(14):1816\u20131821","journal-title":"Mult Scler J"},{"key":"3746_CR128","unstructured":"Healthline. Multiple sclerosis 2021. https:\/\/www.healthline.com\/search?q1=multiple%20sclerosis."},{"issue":"4","key":"3746_CR129","doi-asserted-by":"publisher","first-page":"575","DOI":"10.15171\/apb.2018.066","volume":"8","author":"S Mojaverrostami","year":"2018","unstructured":"Mojaverrostami S, Bojnordi MN, Ghasemi-Kasman M, Ebrahimzadeh MA, Hamidabadi HG (2018) A review of herbal therapy in multiple sclerosis. Adv Pharmaceut Bull 8(4):575","journal-title":"Adv Pharmaceut Bull"},{"key":"3746_CR130","unstructured":"Today MSN. MS Statistics 2020. https:\/\/multiplesclerosisnewstoday.com\/multiple-sclerosis-overview\/statistics\/."},{"key":"3746_CR131","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.clim.2016.06.005","volume":"169","author":"LC Arruda","year":"2016","unstructured":"Arruda LC, de Azevedo JT, de Oliveira GL, Scortegagna GT, Rodrigues ES, Palma PV et al (2016) Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation. Clin Immunol 169:47\u201357","journal-title":"Clin Immunol"},{"issue":"4","key":"3746_CR132","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1007\/s12035-017-0566-7","volume":"55","author":"J Xiao","year":"2018","unstructured":"Xiao J, Yang R, Biswas S, Zhu Y, Qin X, Zhang M et al (2018) Neural stem cell-based regenerative approaches for the treatment of multiple sclerosis. Mol Neurobiol 55(4):3152\u20133171","journal-title":"Mol Neurobiol"},{"key":"3746_CR133","first-page":"1","volume":"11","author":"G Shroff","year":"2018","unstructured":"Shroff G (2018) A review on stem cell therapy for multiple sclerosis: special focus on human embryonic stem cells. Stem Cells Cloning 11:1","journal-title":"Stem Cells Cloning"},{"issue":"6","key":"3746_CR134","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/acm.2006.6355","volume":"13","author":"CC Xue","year":"2007","unstructured":"Xue CC, Zhang AL, Lin V, Da Costa C, Story DF (2007) Complementary and alternative medicine use in Australia: a national population-based survey. J Altern Complement Med 13(6):643\u2013650","journal-title":"J Altern Complement Med"},{"key":"3746_CR135","doi-asserted-by":"crossref","unstructured":"Fumia A, Cicero N, Gitto M, Nicosia N, Alesci A (2021) Role of nutraceuticals on neurodegenerative diseases: neuroprotective and immunomodulant activity. Nat Prod Res 1\u201318.","DOI":"10.1080\/14786419.2021.2020265"},{"issue":"2","key":"3746_CR136","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/molecules27020424","volume":"27","author":"A Alesci","year":"2022","unstructured":"Alesci A, Nicosia N, Fumia A, Giorgianni F, Santini A, Cicero N (2022) Resveratrol and immune cells: a link to improve human health. Molecules (Basel, Switzerland) 27(2):424","journal-title":"Molecules (Basel, Switzerland)"},{"key":"3746_CR137","doi-asserted-by":"crossref","unstructured":"Muresanu D, Balea M, Verisezan Rosu O, Buzoianu A, Slavoaca D (2016) Neuroprotection and recovery in multiple sclerosis. In Trending topics in multiple sclerosis. IntechOpen.","DOI":"10.5772\/63829"},{"issue":"2","key":"3746_CR138","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bcp.2005.04.041","volume":"70","author":"R Verbeek","year":"2005","unstructured":"Verbeek R, van Tol EA, van Noort JM (2005) Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice. Biochem Pharmacol 70(2):220\u2013228","journal-title":"Biochem Pharmacol"},{"key":"3746_CR139","first-page":"1626","volume":"12","author":"Y-X Guo","year":"2021","unstructured":"Guo Y-X, Zhang Y, Gao Y-H, Deng S-Y, Wang L-M, Li C-Q et al (2021) Role of plant-derived natural compounds in experimental autoimmune encephalomyelitis: a review of the treatment potential and development strategy. Front Pharmacol 12:1626","journal-title":"Front Pharmacol"},{"issue":"10","key":"3746_CR140","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.3390\/nu12102907","volume":"12","author":"GR Gandhi","year":"2020","unstructured":"Gandhi GR, Vasconcelos ABS, Wu D-T, Li H-B, Antony PJ, Li H et al (2020) Citrus flavonoids as promising phytochemicals targeting diabetes and related complications: a systematic review of in vitro and in vivo studies. Nutrients 12(10):2907","journal-title":"Nutrients"},{"key":"3746_CR141","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fphar.2018.00252","volume":"9","author":"J Yang","year":"2018","unstructured":"Yang J, Chen H, Wang Q, Deng S, Huang M, Ma X et al (2018) Inhibitory effect of kurarinone on growth of human non-small cell lung cancer: an experimental study both in vitro and in vivo studies. Front Pharmacol 9:252","journal-title":"Front Pharmacol"},{"key":"3746_CR142","doi-asserted-by":"crossref","unstructured":"Ahmed OM, Fahim HI, Ahmed HY, Al-Muzafar HM, Ahmed RR, Amin KA et al (2019) The preventive effects and the mechanisms of action of navel orange peel hydroethanolic extract, naringin, and naringenin in N-acetyl-p-aminophenol-induced liver injury in Wistar rats. Oxidat Med Cell Longev 2019.","DOI":"10.1155\/2019\/2745352"},{"key":"3746_CR143","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.lfs.2018.07.001","volume":"207","author":"S Baradaran","year":"2018","unstructured":"Baradaran S, Hajizadeh Moghaddam A, Ghasemi-Kasman M (2018) Hesperetin reduces myelin damage and ameliorates glial activation in lysolecithin-induced focal demyelination model of rat optic chiasm. Life Sci 207:471\u2013479","journal-title":"Life Sci"},{"issue":"1","key":"3746_CR144","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3945\/an.114.007500","volume":"6","author":"I Solanki","year":"2015","unstructured":"Solanki I, Parihar P, Mansuri ML, Parihar MS (2015) Flavonoid-based therapies in the early management of neurodegenerative diseases. Adv Nutr 6(1):64\u201372","journal-title":"Adv Nutr"},{"issue":"1","key":"3746_CR145","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ctrv.2008.09.005","volume":"35","author":"M Li-Weber","year":"2009","unstructured":"Li-Weber M (2009) New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin. Baicalein Baicalin Cancer Treat Rev 35(1):57\u201368","journal-title":"Baicalein Baicalin Cancer Treat Rev"},{"issue":"2 Suppl","key":"3746_CR146","first-page":"S15","volume":"19","author":"MJ Tullman","year":"2013","unstructured":"Tullman MJ (2013) Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manag Care 19(2 Suppl):S15-20","journal-title":"Am J Manag Care"},{"issue":"6","key":"3746_CR147","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3390\/molecules25061401","volume":"25","author":"M Wei","year":"2020","unstructured":"Wei M, Zhao R, Peng X, Feng C, Gu H, Yang L (2020) Ultrasound-assisted extraction of taxifolin, diosmin, and quercetin from Abies nephrolepis (Trautv.) maxim: kinetic and thermodynamic characteristics. Molecules (Basel, Switzerland). 25(6):1401","journal-title":"Molecules (Basel, Switzerland)."},{"issue":"2","key":"3746_CR148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172477","volume":"12","author":"W Xu","year":"2017","unstructured":"Xu W, Liu J, Ma D, Yuan G, Lu Y, Yang Y (2017) Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats. PLoS ONE 12(2):e0172477","journal-title":"PLoS ONE"}],"updated-by":[{"DOI":"10.1007\/s11064-024-04100-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000}}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03746-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-022-03746-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03746-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:44:25Z","timestamp":1728002665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-022-03746-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":148,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["3746"],"URL":"https:\/\/doi.org\/10.1007\/s11064-022-03746-2","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"assertion":[{"value":"17 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11064-024-04100-4","URL":"https:\/\/doi.org\/10.1007\/s11064-024-04100-4","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}